Epilepsy Foundation: New Therapy Commercialisation Grant Programme – Letters of Intent

Award Title: New Therapy Commercialisation Grant Programme

CALHN Internal Closing Date: 28 January 2018

This supports the development of new therapies for epilepsy, including medicines, biologics or devices. The programme also encourages one-to-one matching grants to academic and commercial entities to support the commercialisation of novel approaches to the treatment of epilepsy. Areas of interest include:

  • novel approaches to treatment;
  • platform technology to advance screening techniques that can be utilised by multiple laboratories, including utility of techniques for early proof-of-concept trials;
  • adaptation of treatment in development for another therapeutic area to assess utility for epilepsy.

Please note: Applicants are strongly encouraged to discuss their proposals with Adelaide Enterprise in terms of potential commercial partners or commercialisation path.

FUNDING AND DURATION

Grants are worth up to USD $350,000 (approx AUD $484,000) for one to two years.

ELIGIBILITY

Investigators worldwide may apply. Preference is given to proposals that:

  • already have a commercial partner engaged to assist with development,
  • that have committed matching funding from a third party source,
  • that might not otherwise be funded through traditional sources, and
  • that encourage collaboration between scientists and industry.

SUBMISSION TO THE SPONSOR DUE DATE 28 JANUARY 2019

CALHN SUBMISSION REQUIREMENTS

TQEH Research staff (Clinical and Affiliate Title Holders) affiliated with the University of Adelaide, and Non-affiliated staff  Please co-ordinate your application through TQEH Research Secretariat.
Contact: Gwenda Graves phone: 8222 6870 gwenda.graves@sa.gov.au

RAH and SA PATHOLOGY Research staff (Clinical and Affiliate Title Holders) affiliated with the University of Adelaide, and Non-affiliated staff  Please co-ordinate your application through CALHN  Research Office.
Contact:  7117 2217  Health.CALHNResearchGrants@sa.gov.au

SUBMISSION BY UNIVERSITY OF ADELAIDE RESEARCHERS

  • 28 January 2019 – Letters of Intent submitted directly to Sponsor
  • 25 March 2019 – Invited applications submitted for internal review
  • Please email rbinternational@adelaide.edu.au if you are considering applying for this scheme.

Submit an Application to Research Services for Review

SUBMISSION BY UNIVERSITY OF SOUTH AUSTRALIA RESEARCHERS
For submission details please contact:
Research and Innovation Services
University of South Australia
Mawson Lakes Campus
Phone: 8302 3247

All UniSA applications require a completed and signed hard copy of the Grant Application Coversheet to accompany the application.
Refer to the UniSA funding calendar here.

For further information and application instructions please visit: 

https://www.epilepsy.com/make-difference/research-and-new-therapies/innovation/epilepsy-therapy-project/new-therapy

Return to Grants